Each week, Pharmaceutical Technology’s journalists explore movements in job postings that shed light on hiring trends in our sector. These job signals provide insights into where the leading companies are focusing their recruitment efforts, and why. We reveal the skills that are in high demand in the sector, and the themes driving current hiring patterns.  

This new, thematic jobs coverage is powered by our underlying Disruptor data which tracks all major deals, patents, company filings, hiring patterns and social media buzz across our sectors.  

This week, we take a look at hiring trends in the pharma industry over the last four months, encompassing Q2 2023 and the month of July. The US continues to be the top country with the most active job listings in the pharma sector recorded in the last four months. The number of active job listings in this space has been trending upwards in the US and China, with the exception of the month of July where the data extends only till 26 July.

While the number of listings have increased, this period has also been marked by several small biotechs and large pharma companies announcing layoffs. Earlier this month, Amarin announced layoffs to counter decreasing revenues for its lead drug Vascepa following the entry of generics. The Boston, Massachusetts-based Pieris Pharma also said it plans to lay off 70% of its workforce after a significant collaboration with AstraZeneca was terminated.

This article is based on information from GlobalData’s Jobs analytics database, which tracks jobs listings for companies in several sectors, including pharma, on a daily basis. To know more about this database, click here.